Daniel D. Gretler
Corporate Officer/Principal bei Stanford University
Aktive Positionen von Daniel D. Gretler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Stanford University | Corporate Officer/Principal | 01.01.2001 | - |
Karriereverlauf von Daniel D. Gretler
Ehemalige bekannte Positionen von Daniel D. Gretler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1995 | 01.01.2002 |
Syntex (USA), Inc.
Syntex (USA), Inc. Pharmaceuticals: MajorHealth Technology Part of Roche Bay Plc, Syntex (USA), Inc. is a company that manufactures and wholesales pharmaceutical products. The company is based in Palo Alto, CA. | Corporate Officer/Principal | 01.01.1992 | 01.01.1995 |
The University of Chicago | Corporate Officer/Principal | 01.01.1990 | 01.01.1992 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
PORTOLA PHARMACEUTICALS, INC. | Public Communications Contact | 01.01.2003 | 05.11.2009 |
General Counsel | 01.01.2003 | - |
Ausbildung von Daniel D. Gretler
University of Bern | Doctorate Degree |
University of Southern California | Undergraduate Degree |
The University of Chicago | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Schweiz | 2 |
Operativ
Corporate Officer/Principal | 4 |
Undergraduate Degree | 2 |
Public Communications Contact | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 5 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | Health Technology |
Syntex (USA), Inc.
Syntex (USA), Inc. Pharmaceuticals: MajorHealth Technology Part of Roche Bay Plc, Syntex (USA), Inc. is a company that manufactures and wholesales pharmaceutical products. The company is based in Palo Alto, CA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Daniel D. Gretler
- Erfahrung